Skip to content

Repligen RGEN Interest Expense

Interest Expense at other companies

TEC
Bio-TechneTECH
$2.13M-45.9%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$354M+16.8%
Danaher logo
DanaherDHR
$63M-12.5%
Agilent Technologies logo
Agilent TechnologiesA
$25M-13.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$12.3M+2.5%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's interest expense?
Repligen (RGEN) reported interest expense of $5.58M in Q1 2026.
How has Repligen's interest expense changed year-over-year?
Repligen's interest expense increased by 6.2% year-over-year, from $5.25M to $5.58M.
What is the long-term trend for Repligen's interest expense?
Over 2 years (2021 to 2023), Repligen's interest expense has grown at a -55.6% compound annual growth rate (CAGR), from $11.28M to $2.23M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.